Fuscalpel is at the cutting edge of High-Intensity Focused Ultrasound (HIFU) technology, pioneering non-invasive medical treatments with our proprietary HIFU device. This revolutionary tool has been instrumental in supporting over 100 hospitals and has provided benefits to more than 40,000 patients around the world. Our technology distinguishes itself through innovation, having addressed and overcome numerous engineering and medical challenges.Our device has garnered essential regulatory approvals, achieving significant milestones in the global healthcare landscape. It has navigated through the rigorous CFDA (China) approval process, earned the CE marking for Europe, and obtained licenses in crucial markets, including Korea, Taiwan, Hong Kong, and Indonesia. These accomplishments highlight Fuscalpel's significant impact as a leading force in non-invasive treatment solutions, showcasing our dedication to delivering safe and effective healthcare options worldwide.